Hydroxychloroquine sulfate tablets for patients with recurrent implantation failure: a double-blind, randomized, placebo-controlled trial

Key Points

• To assess the efficacy of hydroxychloroquine sulfate tablets in patients experiencing recurrent implantation failure.
• Conducted a double-blind, randomized, placebo-controlled trial.
• Enrolled patients with recurrent implantation failure.
• Administered hydroxychloroquine sulfate versus a placebo.
• The treatment group showed improved outcomes in implantation rates.
• Participants reported fewer side effects compared to the placebo group.